Work

Abstract A041: Emergence of TOP1 mutations as a potential biomarker of resistance to topoisomerase-targeting regimens

Year: 2025

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-25-a041

Authors: Tejaswini P. Reddy, Lei Kang, Hung Le, Senthil Damodaran, Kanwal Raghav, Scott Kopetz, Jordi Rodon Ahnert, Ecaterina E. Dumbrava, Timothy A. Yap, Stephen Williams, Mark J. Routbort, Keyur P. Patel, Funda Meric-Bernstam

Institutions: Baylor College of Medicine, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7093306273

Cites:

Cited by: 1

Related to: